Chiesi USA Appoints VP of Medical Affairs

Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A., has appointed Martin Marciniak, RPh, MPP, PhD, as Vice President of Medical Affairs.

With more than 20 years of experience in the pharmaceutical field, Marciniak will provide strategic input to late-stage drug development and drive Chiesi post-marketing clinical efforts.

“Martin holds a proven track record of delivering medical and health economic results in support of healthcare providers, payers and policy makers in specialty care therapeutics,” said Jon Zwinski, General Manager and CEO of Chiesi USA. “With his demonstrated leadership and expertise, Martin is a remarkable addition to Chiesi USA, and I’m excited for him to lead our medical affairs team as we grow our therapeutic areas.”

Marciniak brings significant experience in medical affairs, market access, research and development, partnerships and mergers, with broad knowledge of the healthcare and managed care industry at a global and local level. In his most recent role as Vice President of U.S. Medical Affairs for GlaxoSmithKline leading Customer Engagement, Value, Evidence and Outcomes, he delivered key performance metrics through executing strategic and tactical plans to ensure market access for therapies. Other roles he held at GSK included Interim Head of the Respiratory Therapeutic Area and Vice President of US Health Outcomes and Medical Policy.

“It is an honor to join Chiesi USA at this time of exciting growth,” said Marciniak. “I look forward to supporting the team to deliver meaningful value and results for patients and providers alike.”

Prior to his time at GSK, Marciniak served as Senior Director of Global Health Outcomes at Eli Lilly and Company, where he led cross-functional U.S. teams in the design, development and execution of the first prospective oncology observational study in underrepresented populations.

Marciniak earned his Doctorate degree from the University of California at Berkeley, his Master of Public Policy degree from the Kennedy School of Government at Harvard University and his Bachelor of Science degree in pharmacy from Purdue University.